It was reported in the patient's medical records that as a result of having the product implanted, the patient has experienced urinary frequency, external irritation of the outside vulva, dysuria (burning, itching with urination), recurrent urinary tract infections (enterococcus and escherichia coli), dribbling, inability to control bladder, ammonia-like smell to urine, unstable bladder with bladder irritability, overactive bladder, bladder spasm, leakage of urine with coughing, moderate cystocele, residual urinary incontinence, mixed incontinence, failed trial of vesicare, intrinsic sphincter deficiency, urge incontinence, mild-to-moderate trabeculation (cystoscopy findings (b)(6) 2010), squamous metaplasia with mild chronic inflammation of left trigone (surgical pathology (b)(6) 2010), acute kidney injury (likely due to prerenal azotemia thought related to diuretics, episodes of relative hypotension, and celebrex), urinary tract infection, chronic back pain, vulvovaginal symptoms (burning, itching, and yellowish discharge), incomplete bladder voiding, frequent nighttime urination, mild suprapubic tenderness with palpation, postmenopausal atrophic vaginitis, pelvic pressure, pain or discomfort in the lower abdomen or genital region, urine leakage associated with a strong sensation of needing to go, decreased libido, herniated lumbar disc, lumbar spinal stenosis, lumbar spine spondylosis, lumbar spine scoliosis, lumbar radicular pain, progression of lumbar degenerative changes (noted on x-ray (b)(6) 2013 - compared to (b)(6) 2009), left abdominal subcutaneous masses, diaper rash (possible allergy to diaper/pads for urine incontinence or candidiasis), chronic mild kidney disease, diabetes with renal manifestations, dermatophytosis of groin and perianal area (left groin pain with burning sensation), and yellowish discharge on adult diapers and sanitary pads with an ammonia-like odor, unspecified pain, unspecified infection, unspecified urinary problems, unspecified recurrence, dyspareunia, unspecified neuromuscular problems, vaginal scarring, unspecified "other" outcomes, and loss of consortium.The patient subsequently underwent cystourethroscopy and bladder biopsies ((b)(6) 2010); cystourethroscopy and contigen bulking agent injection to the internal sphincter x 2 ((b)(6) 2010); interstim test ((b)(6) 2012); and stage 1 interstim, stage 2 interstim, intraoperative neurophysiologic testing, and intraoperative fluoroscopy ((b)(6) 2012).
|